IGF2BP1 and hepatocellular carcinoma: Firstly, results found that oxaliplatin sensitivity analysis revealed that overexpressing IGF2BP1 increased the IC50 value (the concentration of oxaliplatin needed to achieve a 50% reduction in absorbance relative to the control) of HCC cells, whereas IGF2BP1 silencing reduced the IC50 value (Figures 2C, D).